Kazuhiko Kuriyama

This inventor holds 9 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 2005-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhiko Kuriyama. Retrieved from https://idiyas.com/inventor/kazuhiko-kuriyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 2)

% Patents Active = 44.4

CIPO Patents = 3

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 105(Granted Patents)

Company Filing History:

9 out of 185

Kyorin Pharmaceutical Co., Ltd.

patents

Years Active: 2005-2012

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8273748 - Amino alcohol derivative and immunosuppresive agent having same as an active ingredient (2012-09-25),

2. 7807854 - Effective use method of medicaments and method of preventing expression of side effect (2010-10-05),

3. 7781617 - Effective use method of medicaments and method of preventing expression of side effect (2010-08-24),

4. 7763752 - Amino alcohol derivatives, salts thereof and immunosuppresive agents (2010-07-27),

5. 7759326 - Aminophosphonic acid derivative, salt thereof, and modulator of S1P receptor (2010-07-20),

6. 7482491 - Amino alcohol derivative, addition salt thereof, and immunosuppressant (2009-01-27),

7. 7456157 - Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators (2008-11-25),

8. 6963012 - Diaryl ether derivative, addition salt thereof, and immunosuppressant (2005-11-08),

9. 6960692 - Diaryl sulfide derivative, addition salt thereof, and immunosuppressant (2005-11-01),

Title: Kazuhiko Kuriyama: Innovator in Immunosuppressive Agents

Introduction

Kazuhiko Kuriyama is a prominent inventor based in Tochigi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of immunosuppressive agents. With a total of nine patents to his name, Kuriyama's work has had a substantial impact on medical science.

Latest Patents

Kuriyama's latest patents include an amino alcohol derivative and an immunosuppressive agent that utilizes this compound as an active ingredient. This amino alcohol derivative has been identified as an excellent immunosuppressive agent through extensive research aimed at creating a highly safe compound with superior immunosuppressive activity. Additionally, he has developed a method for effectively using medicaments that express immunosuppressive or anti-inflammatory agents while minimizing side effects. This medicament incorporates diaryl sulfide or diaryl ether compounds with a 2-amino-1,3-propanediol structure, which helps reduce the number of circulating lymphocytes in combination with an immunosuppressive agent and/or an anti-inflammatory agent.

Career Highlights

Kuriyama has built a successful career at Kyorin Pharmaceutical Co., Ltd., where he has been instrumental in advancing pharmaceutical research and development. His innovative approaches have led to breakthroughs in the treatment of various medical conditions.

Collaborations

Throughout his career, Kuriyama has collaborated with notable colleagues, including Yasushi Kohno and Shinji Kudou. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Kazuhiko Kuriyama's contributions to the field of immunosuppressive agents exemplify his dedication to advancing medical science. His innovative patents and collaborative efforts continue to influence the pharmaceutical industry positively.

Profile summary based on public USPTO records.